Skip to Main Content

Author Details

Tadashi Kondo
Nagasaki University Graduate School of Biomedical Sciences
1997
191
36
Emma Lundberg (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36258091Correction to: Establishment and characterization of NCC-MRT1-C1: a novel cell line of malignant rhabdoid tumor.Hum Cell2023
37490236Establishment and characterization of NCC-DFSP4-C1: a novel cell line from a patient with dermatofibrosarcoma protuberans having the fibrosarcomatous transformation.Hum Cell2023
35714342Prognostic Role for Primary Tumor Location in Patients With Colorectal Liver Metastases: A Comparison of Right-Sided Colon, Left-Sided Colon, and Rectum.Dis Colon Rectum2023
37229542Integrating analysis of proteome profile and drug screening identifies therapeutic potential of MET pathway for the treatment of malignant peripheral nerve sheath tumor.Expert Rev Proteomics2023
37328637Establishment and characterization of two novel patient-derived cell lines from giant cell tumor of bone.Hum Cell2023
36959380Functional genomics of human clear cell sarcoma: genomic, transcriptomic and chemical biology landscape for clear cell sarcoma.Br J Cancer2023
36849535Subtype-selective induction of apoptosis in translocation-related sarcoma cells induced by PUMA and BIM upon treatment with pan-PI3K inhibitors.Cell Death Dis2023
36810562Comprehensive Kinase Activity Profiling Revealed the Kinase Activity Patterns Associated with the Effects of EGFR Tyrosine Kinase Inhibitor Therapy in Advanced Non-Small-Cell Lung Cancer Patients with Sensitizing EGFR Mutations.Proteomes2023
36436139Establishment and characterization of NCC-PLPS2-C1: a novel cell line of pleomorphic liposarcoma.Hum Cell2023
36629983Establishment and characterization of NCC-DSM1-C1: a novel cell line derived from a patient with desmoid fibromatosis.Hum Cell2023
36258092Correction to: Establishment and characterization of NCC-GCTB5-C1: a novel cell line of giant cell tumor of bone.Hum Cell2023
34775549Establishment and characterization of NCC-MPNST6-C1: a novel patient-derived cell line of malignant peripheral nerve sheath tumors.Hum Cell2022
35653034Establishment and characterization of NCC-GCTB5-C1: a novel cell line of giant cell tumor of bone.Hum Cell2022
35613108Proteomic and microbiota analyses of the oral cavity during psychological stress.PLoS One2022
35637403Establishment and characterization of two novel patient-derived myxoid liposarcoma cell lines.Hum Cell2022
35655041Establishment and characterization of NCC-SS5-C1: a novel patient-derived cell line of synovial sarcoma.Hum Cell2022
35927606Establishment and characterization of NCC-MRT1-C1: a novel cell line of malignant rhabdoid tumor.Hum Cell2022
35315355WEE1 kinase is a therapeutic vulnerability in CIC-DUX4 undifferentiated sarcoma.JCI Insight2022
35069873Establishment and characterization of NCC-DMM1-C1, a novel patient-derived cell line of desmoplastic malignant pleural mesothelioma.Oncol Lett2022
35118583Establishment and characterization of NCC-UPS4-C1: a novel cell line of undifferentiated pleomorphic sarcoma from a patient with Li-Fraumeni syndrome.Hum Cell2022
35207746Establishment and Characterization of NCC-PMP1-C1: A Novel Patient-Derived Cell Line of Metastatic Pseudomyxoma Peritonei.J Pers Med2022
35053323Establishment and Characterization of NCC-MFS5-C1: A Novel Patient-Derived Cell Line of Myxofibrosarcoma.Cells2022
35338344Transferrin receptor 1 promotes the fibroblast growth factor receptor-mediated oncogenic potential of diffused-type gastric cancer.Oncogene2022
35292923Establishment and characterization of NCC-DDLPS5-C1: a novel patient-derived cell line of dedifferentiated liposarcoma.Hum Cell2022
32986888Current status and future outlook for patient-derived cancer models from a rare cancer research perspective.Cancer Sci2021
33685520C11orf95-RELA fusion drives aberrant gene expression through the unique epigenetic regulation for ependymoma formation.Acta Neuropathol Commun2021
33677797Establishment and characterization of NCC-DDLPS3-C1: a novel patient-derived cell line of dedifferentiated liposarcoma.Hum Cell2021
33531202Kinome profiling analysis identified Src pathway as a novel therapeutic target in combination with histone deacetylase inhibitors for cutaneous T-cell lymphoma.J Dermatol Sci2021
33555519Establishment and characterization of a novel cell line, NCC-DDLPS2-C1, derived from a patient with dedifferentiated liposarcoma.Hum Cell2021
34383271Establishment and characterization of NCC-MFS4-C1: a novel patient-derived cell line of myxofibrosarcoma.Hum Cell2021
34419499Integrative analyses of gene expression and chemosensitivity of patient-derived ovarian cancer spheroids link G6PD-driven redox metabolism to cisplatin chemoresistance.Cancer Lett2021
34685592The CAM Model for <i>CIC-DUX4</i> Sarcoma and Its Potential Use for Precision Medicine.Cells2021
34044883Publisher Correction to: C11orf95-RELA fusion drives aberrant gene expression through the unique epigenetic regulation for ependymoma formation.Acta Neuropathol Commun2021
33983905ETV4 and ETV5 drive synovial sarcoma through cell cycle and DUX4 embryonic pathway control.J Clin Invest2021
34304386Establishment and characterization of novel patient-derived cell lines from giant cell tumor of bone.Hum Cell2021
33400690Direct conversion of osteosarcoma to adipocytes by targeting TNIK.JCI Insight2021
33146842Establishment and characterization of NCC-MLPS1-C1: a novel patient-derived cell line of myxoid liposarcoma.Hum Cell2021
32886306Establishment and characterization of a novel cell line, NCC-TGCT1-C1, derived from a patient with tenosynovial giant cell tumor.Hum Cell2021
32997328Drug screening with a novel tumor-derived cell line identified alternative therapeutic options for patients with atypical teratoid/rhabdoid tumor.Hum Cell2021
32710739Artesunate inhibits intestinal tumorigenesis through inhibiting wnt signaling.Carcinogenesis2021
31625124Establishment and characterization of novel patient-derived extraskeletal osteosarcoma cell line NCC-ESOS1-C1.Hum Cell2020
31898195Establishment and characterization of NCC-CDS2-C1: a novel patient-derived cell line of CIC-DUX4 sarcoma.Hum Cell2020
32075980Publisher Correction: Integrated exome and RNA sequencing of dedifferentiated liposarcoma.Nat Commun2020
32099531Establishment and characterization of patient-derived cancer models of malignant peripheral nerve sheath tumors.Cancer Cell Int2020
32648033Establishment and characterization of NCC-ASPS1-C1: a novel patient-derived cell line of alveolar soft-part sarcoma.Hum Cell2020
32899796Current Status and Perspectives of Patient-Derived Models for Ewing's Sarcoma.Cancers (Basel)2020
32815117Establishment and characterization of NCC-GCTB1-C1: a novel patient-derived cancer cell line of giant cell tumor of bone.Hum Cell2020
32214089CDK1 dependent phosphorylation of hTERT contributes to cancer progression.Nat Commun2020
32274656Establishment and characterization of NCC-SS3-C1: a novel patient-derived cell line of synovial sarcoma.Hum Cell2020
32356243Establishment and characterization of NCC-DFSP3-C1: a novel patient-derived dermatofibrosarcoma protuberans cell line.Hum Cell2020
  • 1 - 50 of 191

Recommended Authors

Zitong Zhao
School of Pharmacy, Wannan Medical College
Career Start Year 2012
Number of shared co-authors 0
Shingo Sakashita
National Cancer Center Exploratory Oncology Research & Clinical Trial Center
Career Start Year 2008
Number of shared co-authors 0
Kris Ylaya
Center for Cancer Research, National Cancer Institute
Career Start Year 2008
Number of shared co-authors 1
Liang Cao
National Cancer Institute, National Institutes of Health
Career Start Year 2008
Number of shared co-authors 0
Johannes Haybaeck
Institute of Pathology, Medical University of Innsbruck
Career Start Year 2007
Number of shared co-authors 0
Thomas G P Gr??newald
German Cancer Research Center
Career Start Year 2006
Number of shared co-authors 4
Tuan Zea Tan
Cancer Science Institute of Singapore, National University of Singapore
Career Start Year 2005
Number of shared co-authors 1
Esther Herpel
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 0
Fan Zhang
Huaihe Hospital of Henan University
Career Start Year 2004
Number of shared co-authors 0
Yongmei Song
Shandong University of Traditional Chinese Medicine
Career Start Year 2003
Number of shared co-authors 0
Chantal Pauli
University Hospital Zurich
Career Start Year 2001
Number of shared co-authors 0
Wei Zhang
Children's Hospital, Zhejiang University School of Medicine
Career Start Year 2001
Number of shared co-authors 1
Limei Hu
Aier Eye Hospital of Wuhan University
Career Start Year 2001
Number of shared co-authors 1
Oscar M Tirado
Institut d'Investigacio Biomedica de Bellvitge (IDIBELL)/CIBERONC
Career Start Year 2000
Number of shared co-authors 1
Jilong Yang
Tianjin Medical University Cancer Institute and Hospital
Career Start Year 2000
Number of shared co-authors 1
Fan Yang
West China Second Hospital, Sichuan University
Career Start Year 2000
Number of shared co-authors 0
Beate Rinner
Medical University of Graz
Career Start Year 2000
Number of shared co-authors 0
Jun Yao
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 1
Ni Liu
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year 1997
Number of shared co-authors 0
William M Gallagher
All-Island Cancer Research Institute, UCD Conway Institute, University College Dublin
Career Start Year 1996
Number of shared co-authors 5
Dong Lin
Fujian Medical University Cancer Hospital and Fujian Cancer Hospital
Career Start Year 1996
Number of shared co-authors 0
Hai Hu
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Career Start Year 1996
Number of shared co-authors 0
Woong-Yang Park
Samsung Genome Institute, Samsung Medical Center
Career Start Year 1995
Number of shared co-authors 1
Sang Yong Song
Center for Nanophase Materials Sciences, Oak Ridge National Laboratory
Career Start Year 1995
Number of shared co-authors 0
Enrique de Alava
Servicio de Anatomia Patologica. Hospital Universitario Virgen del Rocio.
Career Start Year 1992
Number of shared co-authors 3
Qimin Zhan
Peking University Cancer Hospital
Career Start Year 1989
Number of shared co-authors 0
Wei Zhang
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 2
Stephen M Hewitt
Center for Cancer Research, National Cancer Institute
Career Start Year 1988
Number of shared co-authors 2
Patrick Kwok-Shing Ng
The University of Texas MD Anderson Cancer Center
Career Start Year 1987
Number of shared co-authors 1
Hoguen Kim
Korea Advanced Institute of Science and Technology (KAIST)
Career Start Year 1982
Number of shared co-authors 4

Collaborators

Rieko Oyama
Co-authored papers 18
Tatsuhiro Shibata
Kurume University School of Medicine
Co-authored papers 15
Samir M Hanash
University of Texas MD Anderson Cancer Center
Co-authored papers 2
Mario R Capecchi
University of Utah School of Medicine
Co-authored papers 2
Seiya Imoto
Human Genome Center, The Institute of Medical Science, The University of Tokyo
Co-authored papers 2
Hidewaki Nakagawa
RIKEN Center for Integrative Medical Sciences
Co-authored papers 2
Frank Szulzewsky
Co-authored papers 2
Satoru Miyano
Tokyo Medical and Dental University
Co-authored papers 2
Gy??rgy Marko-Varga
Clinical Protein Science & Imaging, Biomedical Centre, Lund University
Co-authored papers 1
Takuro Nakamura
Tohoku University Graduate School of Medicine
Co-authored papers 1
Daniel Klevebring
Karolinska Institutet
Co-authored papers 1
Hideya Kawaji
RIKEN Center for Integrative Medical Sciences
Co-authored papers 1
Carl Hamsten
Karolinska Institutet and University Hospital
Co-authored papers 1
Yasushi Ishihama
Graduate School of Pharmaceutical Sciences, Kyoto University
Co-authored papers 1
Per Oksvold
KTH-Royal Institute of Technology
Co-authored papers 1
Jonathan C Trent
Sylvester Comprehensive Cancer Center, University of Miami
Co-authored papers 1
Linn Fagerberg
KTH Royal Institute of Technology
Co-authored papers 1
??sa Sivertsson
KTH-Royal Institute of Technology
Co-authored papers 1
Tak W Mak
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 1
Helmut E Meyer
Co-authored papers 1
Victor Olivas
University of California san francisco
Co-authored papers 1
David M Ornitz
Co-authored papers 1
Richard M Myers
HudsonAlpha Institute for Biotechnology
Co-authored papers 1
Irene L Andrulis
University of Toronto
Co-authored papers 1
David E Fisher
Cutaneous Biology Research Center, Mass. General Hospital, Harvard Medical School
Co-authored papers 1
Jay S Wunder
University of Toronto
Co-authored papers 1
Jacob Odeberg
The Arctic University of Norway
Co-authored papers 1
Noah E Berlow
Children's Cancer Therapy Development Institute
Co-authored papers 1
Kosuke Yoshihara
Co-authored papers 1
Hiroshi Mamitsuka
Institute for Chemical Research, Kyoto University
Co-authored papers 1
Release 1.2